Logo image of ENGN

ENGENE HOLDINGS INC (ENGN) Stock Fundamental Analysis

NASDAQ:ENGN - Nasdaq - CA29286M1059 - Common Stock - Currency: USD

4.2  +0.29 (+7.42%)

After market: 4.01 -0.19 (-4.52%)

Fundamental Rating

2

ENGN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 561 industry peers in the Biotechnology industry. The financial health of ENGN is average, but there are quite some concerns on its profitability. ENGN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ENGN has reported negative net income.
In the past year ENGN has reported a negative cash flow from operations.
In the past 5 years ENGN reported 4 times negative net income.
ENGN had a negative operating cash flow in each of the past 5 years.
ENGN Yearly Net Income VS EBIT VS OCF VS FCFENGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

ENGN's Return On Assets of -24.15% is fine compared to the rest of the industry. ENGN outperforms 72.91% of its industry peers.
ENGN's Return On Equity of -27.62% is fine compared to the rest of the industry. ENGN outperforms 79.50% of its industry peers.
Industry RankSector Rank
ROA -24.15%
ROE -27.62%
ROIC N/A
ROA(3y)-5.96%
ROA(5y)N/A
ROE(3y)-6.79%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ENGN Yearly ROA, ROE, ROICENGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 2K 4K 6K

1.3 Margins

ENGN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ENGN Yearly Profit, Operating, Gross MarginsENGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024

More info and screens

5

2. Health

2.1 Basic Checks

ENGN has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, ENGN has a worse debt to assets ratio.
ENGN Yearly Shares OutstandingENGN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M 40M 50M
ENGN Yearly Total Debt VS Total AssetsENGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

ENGN has an Altman-Z score of 2.18. This is not the best score and indicates that ENGN is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of ENGN (2.18) is better than 73.26% of its industry peers.
ENGN has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.09, ENGN is not doing good in the industry: 64.53% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z 2.18
ROIC/WACCN/A
WACCN/A
ENGN Yearly LT Debt VS Equity VS FCFENGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

ENGN has a Current Ratio of 17.16. This indicates that ENGN is financially healthy and has no problem in meeting its short term obligations.
ENGN has a better Current ratio (17.16) than 91.80% of its industry peers.
A Quick Ratio of 17.16 indicates that ENGN has no problem at all paying its short term obligations.
The Quick ratio of ENGN (17.16) is better than 91.80% of its industry peers.
Industry RankSector Rank
Current Ratio 17.16
Quick Ratio 17.16
ENGN Yearly Current Assets VS Current LiabilitesENGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for ENGN have decreased strongly by -118.20% in the last year.
EPS 1Y (TTM)-118.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4.59%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 18.23% on average over the next years. This is quite good.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-39.02%
EPS Next 2Y-25.6%
EPS Next 3Y-6.72%
EPS Next 5Y18.23%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ENGN Yearly Revenue VS EstimatesENGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 2031 2032 200M 400M 600M
ENGN Yearly EPS VS EstimatesENGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 2 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ENGN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ENGN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ENGN Price Earnings VS Forward Price EarningsENGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ENGN Per share dataENGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

A cheap valuation may be justified as ENGN's earnings are expected to decrease with -6.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-25.6%
EPS Next 3Y-6.72%

More info and screens

0

5. Dividend

5.1 Amount

ENGN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ENGENE HOLDINGS INC

NASDAQ:ENGN (5/20/2025, 8:00:01 PM)

After market: 4.01 -0.19 (-4.52%)

4.2

+0.29 (+7.42%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-10 2025-03-10/amc
Earnings (Next)06-11 2025-06-11
Inst OwnersN/A
Inst Owner Change-1.35%
Ins OwnersN/A
Ins Owner Change0%
Market Cap214.12M
Analysts84.71
Price Target24.48 (482.86%)
Short Float %N/A
Short Ratio1.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.51%
Min EPS beat(2)-26.76%
Max EPS beat(2)11.73%
EPS beat(4)2
Avg EPS beat(4)-10.22%
Min EPS beat(4)-42.19%
Max EPS beat(4)16.34%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-13.36%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-25.87%
EPS NY rev (1m)0%
EPS NY rev (3m)-23.15%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.86
P/tB 0.86
EV/EBITDA N/A
EPS(TTM)-1.52
EYN/A
EPS(NY)-2.28
Fwd EYN/A
FCF(TTM)-1.32
FCFYN/A
OCF(TTM)-1.31
OCFYN/A
SpS0
BVpS4.9
TBVpS4.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.15%
ROE -27.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-5.96%
ROA(5y)N/A
ROE(3y)-6.79%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 208.12%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 17.16
Quick Ratio 17.16
Altman-Z 2.18
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)177.46%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-118.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4.59%
EPS Next Y-39.02%
EPS Next 2Y-25.6%
EPS Next 3Y-6.72%
EPS Next 5Y18.23%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-305.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-89.82%
EBIT Next 3Y-34.1%
EBIT Next 5Y14.4%
FCF growth 1Y-7139.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-7062.04%
OCF growth 3YN/A
OCF growth 5YN/A